A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists

被引:28
作者
Hariprasad, V [1 ]
Kulkarni, VM [1 ]
机构
[1] UNIV BOMBAY, DEPT CHEM TECHNOL, DIV PHARMACEUT, BOMBAY 400019, MAHARASHTRA, INDIA
关键词
conformational analysis; pharmacophore; 3D QSAR; pLT receptor antagonists;
D O I
10.1007/BF00124498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Molecular modeling studies were carried out by a combined use of conformational analysis and 3D-QSAR methods to identify molecular features common to a series of hydroxyacetophenone (HAP) and non-hydroxyacetophenone (non-HAP) peptide leukotriene (pLT) receptor antagonists, In attempts to develop a ligand-binding model for the pLT receptor, the Apex-3D program was used to identify biophoric structural patterns that are common to 13 diverse sets of compounds showing different levels of biological activity. A systematic conformational analysis was carried out to obtain sterically accessible conformations for these flexible compounds. Apex-3D was then utilized to propose common biophoric regions based on the selection of one of several conformations (MOPAC-minimized AM1) from each compound's data set that best fits the biophoric pattern and the resulting superimposition with all the other data-set compounds. Apex-3D identified three common biophoric features important for activity: one as the hydroxyl, acetyl, carbonyl and carboxyl groups, which mimic the acid-binding region of an agonist, the other as the hydrogen-bond donating site, and the third part is represented by a plane in which lipophilic aromatic groups align. The structure-activity relationships were then assessed by using the 3D-QSAR model. A common biophore model is proposed from the Apex-3D analysis which may he useful in designing new pLT antagonists. Molecular volumes and electrostatic potential similarities were also calculated in order to obtain the important structural requirements for the activity.
引用
收藏
页码:284 / 292
页数:9
相关论文
共 28 条
[1]
*BIOS TECHN INC, 1995, INSIGHT 2 V 2 3 5
[2]
BROWN JF, 1990, J MED CHEM, V33, P1171
[3]
STEREOSPECIFIC TOTAL SYNTHESIS OF A SLOW REACTING SUBSTANCE OF ANAPHYLAXIS, LEUKOTRIENE C-1 [J].
COREY, EJ ;
CLARK, DA ;
GOTO, G ;
MARFAT, A ;
MIOSKOWSKI, C ;
SAMUELSSON, B ;
HAMMARSTROM, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1980, 102 (04) :1436-1439
[4]
THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909
[5]
LEUKOTRIENE RECEPTOR ANTAGONISTS .2. THE [[(TETRAZOL-5-YLARYL)OXY]METHYL]ACETOPHENONE DERIVATIVES [J].
DILLARD, RD ;
CARR, FP ;
MCCULLOUGH, D ;
HAISCH, KD ;
RINKEMA, LE ;
FLEISCH, JH .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (05) :911-918
[6]
SEMIEMPIRICAL AM1 ELECTROSTATIC POTENTIALS AND AM1 ELECTROSTATIC POTENTIAL DERIVED CHARGES - A COMPARISON WITH ABINITIO VALUES [J].
FERENCZY, GG ;
REYNOLDS, CA ;
RICHARDS, WG .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (02) :159-169
[7]
LEUKOTRIENE RECEPTOR ANTAGONISTS .4. SYNTHESIS AND LEUKOTRIENE D4/E4 RECEPTOR ANTAGONIST ACTIVITY OF 4-(ALKYL)ACETOPHENONE DERIVATIVES [J].
GAPINSKI, DM ;
ROMAN, CR ;
RINKEMA, LE ;
FLEISCH, JH .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (01) :172-175
[8]
GOLENDER VE, 1993, 3D QSAR DRUG DESIGN, P137
[9]
GOOD AC, 1989, J CHEM INF COMP SCI, V32, P3
[10]
DEVELOPMENT OF A SERIES OF PHENYLTETRAZOLE LEUKOTRIENE-D4 (LTD4) RECEPTOR ANTAGONISTS [J].
HARPER, RW ;
HERRON, DK ;
BOLLINGER, NG ;
SAWYER, JS ;
BALDWIN, RF ;
ROMAN, CR ;
RINKEMA, LE ;
FLEISCH, JH .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (07) :1191-1200